Taiwanese researchers used a cohort of 37,894 patients with type 2 diabetes and high cholesterol levels and found that those on statins had a significantly reduced risk of developing diabetic retinopathy, compared with those not taking statins. Published in JAMA Ophthalmology, findings revealed that the statin group also had lower risks of new-onset diabetic neuropathy, new-onset diabetic foot ulcers and major adverse cardiovascular events than the non-statin group.
Statins tied to reduced diabetic retinopathy risk, study finds
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.